Caleb Jones has had a tumultuous season, suffering multiple injuries and a suspension. On March 18, he underwent successful surgery on his right shoulder at the Steadman Clinic. The expected recovery time is four to six months, which means he will miss the rest of the 2025-26 NHL season.
Jones had previously been sidelined for almost three months earlier in the season due to a lower-body injury. Additionally, he faced a 20-game suspension for violating the NHL/NHLPA Performance Enhancing Substances Program. This series of setbacks has significantly impacted his playing time.
Throughout his NHL career, Jones has appeared in 255 regular-season games, scoring 14 goals and providing 42 assists for a total of 56 points. He is currently in the first season of a two-year contract with a cap hit of $900,000.
The Pittsburgh Penguins, for whom Jones plays, currently hold a record of 38-22-16 and are positioned second in the Metropolitan Division. The team has expressed optimism regarding Jones’s recovery timeline.
Kyle Dubas, a representative from the Penguins, stated, “The expected recovery time is four to six months and for Jones to be ready for the start of the 2026-27 regular season.” Dan Muse added, “He will be out for six months, which puts his return timeline somewhere near the start of next season.”
Despite the challenges, the organization remains hopeful that Jones will return to action in time for the 2026-27 campaign. Dubas mentioned, “The operation knocks him out for the rest of the season, though the team is optimistic he will be ready to return to action in time for the 2026-27 campaign.”
Jones himself attributed his positive test for performance-enhancing substances to tainted material during his exosome therapy, which has added to the complexities of his season.
As the Penguins continue their season without Jones, the focus will be on his recovery and the potential impact on the team moving forward.
